marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Mersana Therapeutics Financial Ratios 2011-2024 | MRSN
Annual Financial Ratios Mersana Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.3 | -2.8 | -1.8 | -12.7 | -10.8 | -1.6 | -4.7 | - | - | - | - | - | - |
P/S |
15.6 | 21.3 | 7205.8 | 1350.0 | 7.2 | 10.0 | 10.3 | - | - | - | - | - | - |
EPS |
-1.5 | -2.2 | -2.4 | -1.4 | -0.7 | -2.8 | -3.2 | -10.8 | -13.4 | - | - | - | - |
EV (Enterprise Value) |
589 M | 680 M | 216 M | 908 M | 270 M | 116 M | 215 M | 60.4 M | 57.1 M | - | - | - | - |
EBITDA per Share |
0.01 | 0.01 | 0.01 | 0.02 | -0.666 | -2.8 | -3.22 | - | - | - | - | - | - |
EV/EBITDA |
220.8 | -12.1 | -8.5 | -0.7 | -4.0 | - | - | - | - | - | - | ||
PEG |
- | 0.07 | -0.14 | -0.12 | 0.02 | - | - | - | - | - | - | ||
P/B |
15.6 | 6.2 | 2.5 | 4.9 | 3.9 | 12.0 | 2.6 | - | - | - | - | - | - |
P/CF |
-3.4 | -11.5 | -2.2 | -15.0 | -4.4 | -1.9 | -4.1 | - | - | - | - | - | - |
ROE % |
-465.18 | -221.83 | -139.69 | -38.60 | -36.02 | -730.61 | -55.30 | - | - | - | - | - | - |
ROA % |
-75.94 | -61.08 | -82.51 | -32.20 | -26.23 | -81.85 | -29.61 | - | - | - | - | - | - |
ROCE % |
- | - | - | - | -36.18 | -723.31 | -40.08 | - | - | - | - | - | - |
Current Ratio |
1.2 | 1.4 | 2.4 | 6.0 | 4.2 | 1.1 | 3.7 | - | - | - | - | - | - |
DSO |
- | 206.0 | - | - | - | 15.8 | 16.3 | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 206.0 | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 206.0 | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Mersana Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.09 | -0.2 | - | -0.35 | -0.47 | -0.52 | - | -0.61 | -0.55 | -0.59 | - | -0.63 | -0.59 | -0.5 | -0.42 | -0.33 | -0.33 | -0.35 | -0.34 | -0.35 | -0.36 | 0.72 | 0.97 | -0.74 | -0.54 | -0.54 | 0.61 | -0.35 | -6.33 | -6.02 | 0.07 | -4.56 | -3 | -4.31 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | - | 0.01 | - | - | - | 0.01 | 0.01 | - | - | 0.01 | 0.01 | 0.01 | - | 0.02 | 0.01 | 0.01 | - | 0.04 | 0.02 | 0.01 | - | 0.03 | 0.31 | 0.16 | - | 0.35 | 0.21 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-1543.97 | -508.07 | -227.64 | -293.93 | -280.40 | -258.89 | -138.88 | -168.11 | -131.05 | -113.02 | -67.69 | -80.33 | -60.96 | -52.68 | -47.80 | -55.90 | -66.78 | -74.88 | -82.97 | -317.27 | -551.57 | -785.87 | -1020.17 | -785.08 | -585.34 | -385.60 | -185.86 | -168.16 | -88.23 | -8.30 | 47.00 | 49.26 | 24.63 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-52.02 | -62.70 | -52.27 | -71.26 | -74.42 | -77.65 | -57.99 | -78.89 | -80.79 | -76.22 | -51.02 | -61.57 | -48.90 | -43.32 | -39.88 | -44.43 | -51.31 | -55.87 | -60.43 | -73.89 | -87.36 | -100.83 | -114.30 | -96.41 | -97.45 | -98.48 | -99.52 | -87.64 | -71.06 | -54.49 | -24.88 | -26.07 | -13.04 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.0 | 1.1 | 1.2 | 1.2 | 1.4 | 1.3 | 1.4 | 1.4 | 2.1 | 2.2 | 2.4 | 3.5 | 4.4 | 5.0 | 6.0 | 6.0 | 6.0 | 6.0 | 3.7 | 3.7 | 3.7 | 3.7 | 1.1 | 1.1 | 1.1 | 1.1 | 2.1 | 2.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
9.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 323.7 | 31.7 | 170.8 | 1.0 | 35.3 | 19.5 | 10.0 | 18.5 | 21.9 | 11.4 | 19.2 | 19.5 | 8.0 | 29.4 | 7.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
9.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 323.7 | 31.7 | 170.8 | 1.0 | 35.3 | 19.5 | 10.0 | 18.5 | 21.9 | 11.4 | 19.2 | 19.5 | 8.0 | 29.4 | 7.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
9.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 323.7 | 31.7 | 170.8 | 1.0 | 35.3 | 19.5 | 10.0 | 18.5 | 21.9 | 11.4 | 19.2 | 19.5 | 8.0 | 29.4 | 7.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency